Syria Conflict Squeezes Drug Supplies for Major Diseases, WHO Says
This article was originally published in PharmAsia News
Executive Summary
Syria’s local production of medicines, once 90% of the nation’s consumption, has been greatly reduced by the civil war in the country, particularly in the provinces of Aleppo, Damascus and Homs where local drug makers tended to congregate.